Literature DB >> 30048977

Microbiota Quality and Mitochondrial Activity Link with Occurrence of Muscle Cramps in Hemodialysis Patients using Citrate Dialysate: A Pilot Study.

Pierre-Yves Durand1, Carole Nicco2, Didier Serteyn3, David Attaf4, Marvin Edeas2.   

Abstract

BACKGROUND/AIMS: Hemodialysis-associated muscle cramp (HAMC) is a common complication under citrate dialysate (CD) occurring in 30% of cases. Our objectives were to assess the gut microbiota quality, mitochondrial activity, and to investigate their possible relationship with HAMC.
METHODS: Ten end-stage renal disease patients (78.9 ± 2.1 years) treated by hemodialysis (HD) with CD were enrolled and then classified according to the frequency of HAMCs: "frequent HAMCs group" (n = 5) and "absence of HAMCs group" (n = 5). Gut microbiota quality, mitochondrial activity, and some markers of oxidative stress (OS) were investigated.
RESULTS: In patients with cramps, gut microbiota diversity seemed lower and some genera including Helicobacter, Lachnospira, Roseburia, and Haemophilus seemed over-expressed, a significant increase of citratemia and significant lowering mitochondrial function were observed. No difference was observed on the OS markers.
CONCLUSION: This first clinical study revealed a possible dysbiosis of microbiota and a mitochondrial dysfunction into HD patients with cramps under CD compared to patients without cramp.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Citrate dialysate; Hemodialysis; Hypercitratemia; Microbiota; Mitochondria; Muscle cramps

Mesh:

Substances:

Year:  2018        PMID: 30048977     DOI: 10.1159/000490612

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  6 in total

1.  Citric Acid-Containing Dialysate and Survival Rate in the Dialysis Outcomes and Practice Patterns Study.

Authors:  Pablo Ureña-Torres; Brian Bieber; Fitsum Guebre-Egziabher; Rim Ossman; Michel Jadoul; Masaaki Inaba; Bruce M Robinson; Friedrich Port; Christian Jacquelinet; Christian Combe
Journal:  Kidney360       Date:  2021-02-04

Review 2.  From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation.

Authors:  Carole Nicco; Armelle Paule; Peter Konturek; Marvin Edeas
Journal:  Diseases       Date:  2020-04-15

Review 3.  Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm?

Authors:  Ramachandran Vignesh; Chinnambedu Ravichandran Swathirajan; Zaw Htet Tun; Marimuthu Ragavan Rameshkumar; Sunil Suhas Solomon; Pachamuthu Balakrishnan
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

Review 4.  Potential Associations Between Microbiome and COVID-19.

Authors:  Huifen Wang; Haiyu Wang; Ying Sun; Zhigang Ren; Weiwei Zhu; Ang Li; Guangying Cui
Journal:  Front Med (Lausanne)       Date:  2021-12-22

Review 5.  Microbiota medicine: towards clinical revolution.

Authors:  Prisca Gebrayel; Carole Nicco; Souhaila Al Khodor; Jaroslaw Bilinski; Elisabetta Caselli; Elena M Comelli; Markus Egert; Cristina Giaroni; Tomasz M Karpinski; Igor Loniewski; Agata Mulak; Julie Reygner; Paulina Samczuk; Matteo Serino; Mariusz Sikora; Annalisa Terranegra; Marcin Ufnal; Romain Villeger; Chantal Pichon; Peter Konturek; Marvin Edeas
Journal:  J Transl Med       Date:  2022-03-07       Impact factor: 5.531

Review 6.  Mitochondria and microbiota dysfunction in COVID-19 pathogenesis.

Authors:  Jumana Saleh; Carole Peyssonnaux; Keshav K Singh; Marvin Edeas
Journal:  Mitochondrion       Date:  2020-06-20       Impact factor: 4.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.